Xu, L., Zhang, M., Zhang, C., Xiao, H., Zhou, Q., Wang, J., Zheng, G., Su, T., Huang, M., Yang, C., Wang, F., Xiang, B., Chen, H., Kuang, M. (2026). Envafolimab combined with lenvatinib and gemcitabine plus cisplatin in advanced biliary tract cancer as first-line treatment: A multicenter, single-arm, open-label, phase II study (ENLIGHTEN study).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4152